These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 19602899

  • 1. Discordance in human paraoxonase-1 gene between phenotypes and genotypes in chronic kidney disease.
    Paragh G, Seres I, Harangi M, Pocsai Z, Asztalos L, Locsey L, Szeles G, Kardos L, Varga E, Karpati I, Adany R.
    Nephron Clin Pract; 2009; 113(1):c46-53. PubMed ID: 19602899
    [Abstract] [Full Text] [Related]

  • 2. Paraoxonase 192 polymorphism and its relationship to serum lipids in Turkish renal transplant recipients.
    Agachan B, Yilmaz H, Isbir T, Akoglu E.
    Transplant Proc; 2004 Jun; 36(5):1385-6. PubMed ID: 15251338
    [Abstract] [Full Text] [Related]

  • 3. Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
    Dirican M, Akca R, Sarandol E, Dilek K.
    J Nephrol; 2004 Jun; 17(6):813-8. PubMed ID: 15593056
    [Abstract] [Full Text] [Related]

  • 4. Paraoxonase activity in glomerulonephritic patients.
    Gullulu M, Kahvecioglu S, Dirican M, Akdag I, Ocak N, Demircan C, Dilek K, Ersoy A, Yavuz M, Yurtkuran M.
    Ren Fail; 2007 Jun; 29(4):433-9. PubMed ID: 17497465
    [Abstract] [Full Text] [Related]

  • 5. [Low paraoxonase and arylesterase plasma activities in Mexican patients with coronary artery disease].
    Gamboa R, Regalado JC, Huesca-Gómez C, Posadas-Romero C, Verdejo Paris J, Vargas-Alarcón G, Pérez-Méndez O.
    Arch Cardiol Mex; 2008 Jun; 78(4):360-8. PubMed ID: 19205543
    [Abstract] [Full Text] [Related]

  • 6. Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy.
    Kovács TJ, Harris S, Vas TK, Seres I, Short CD, Wittmann IK, Paragh G, Mackness MI, Mackness B, Durrington PN, Nagy JM, Brenchley PE.
    J Nephrol; 2006 Jun; 19(6):732-8. PubMed ID: 17173245
    [Abstract] [Full Text] [Related]

  • 7. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.
    Sirivarasai J, Kaojarern S, Yoovathaworn K, Sura T.
    Chem Biol Interact; 2007 Jul 20; 168(3):184-92. PubMed ID: 17532308
    [Abstract] [Full Text] [Related]

  • 8. Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity.
    Keskin M, Dolar E, Dirican M, Kiyici M, Yilmaz Y, Gurel S, Nak SG, Erdinc S, Gulten M.
    Intern Med J; 2009 Apr 20; 39(4):243-8. PubMed ID: 19402863
    [Abstract] [Full Text] [Related]

  • 9. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
    Can Demirdöğen B, Türkanoğlu A, Bek S, Sanisoğlu Y, Demirkaya S, Vural O, Arinç E, Adali O.
    Clin Biochem; 2008 Jan 20; 41(1-2):1-9. PubMed ID: 17920578
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Paraoxonase1 polymorphism Leu-Met55 is associated with cerebral infarction in Japanese population.
    Ueno T, Shimazaki E, Matsumoto T, Watanabe H, Tsunemi A, Takahashi Y, Mori M, Hamano R, Fujioka T, Soma M, Matsumoto K, Kanmatsuse K.
    Med Sci Monit; 2003 Jun 20; 9(6):CR208-12. PubMed ID: 12824947
    [Abstract] [Full Text] [Related]

  • 12. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.
    Campo S, Sardo MA, Trimarchi G, Bonaiuto M, Fontana L, Castaldo M, Bonaiuto A, Saitta C, Bitto A, Manduca B, Riggio S, Saitta A.
    Exp Gerontol; 2004 Jul 20; 39(7):1089-94. PubMed ID: 15236768
    [Abstract] [Full Text] [Related]

  • 13. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation.
    Serhatlioglu S, Gursu MF, Gulcu F, Canatan H, Godekmerdan A.
    Cell Biochem Funct; 2003 Dec 20; 21(4):371-5. PubMed ID: 14624476
    [Abstract] [Full Text] [Related]

  • 14. Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder.
    Sarandol A, Sarandol E, Eker SS, Karaagac EU, Hizli BZ, Dirican M, Kirli S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug 30; 30(6):1103-8. PubMed ID: 16716479
    [Abstract] [Full Text] [Related]

  • 15. Paraoxonase phenotype distribution in a healthy Iranian population.
    Sepahvand F, Shafiei M, Ghaffari SM, Rahimi-Moghaddam P, Mahmoudian M.
    Basic Clin Pharmacol Toxicol; 2007 Aug 30; 101(2):104-7. PubMed ID: 17651311
    [Abstract] [Full Text] [Related]

  • 16. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
    Christidis DS, Liberopoulos EN, Kakafika AI, Miltiadous GA, Liamis GL, Kakaidi B, Tselepis AD, Cariolou MA, Elisaf MS.
    Arch Med Res; 2007 May 30; 38(4):403-10. PubMed ID: 17416287
    [Abstract] [Full Text] [Related]

  • 17. Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities.
    Bryk B, BenMoyal-Segal L, Podoly E, Livnah O, Eisenkraft A, Luria S, Cohen A, Yehezkelli Y, Hourvitz A, Soreq H.
    J Neurochem; 2005 Mar 30; 92(5):1216-27. PubMed ID: 15715671
    [Abstract] [Full Text] [Related]

  • 18. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus.
    Juretić D, Motejlkova A, Kunović B, Rekić B, Flegar-Mestrić Z, Vujić L, Mesić R, Lukac-Bajalo J, Simeon-Rudolf V.
    Acta Pharm; 2006 Mar 30; 56(1):59-68. PubMed ID: 16613735
    [Abstract] [Full Text] [Related]

  • 19. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.
    Wills AM, Landers JE, Zhang H, Richter RJ, Caraganis AJ, Cudkowicz ME, Furlong CE, Brown RH.
    Neurology; 2008 Mar 18; 70(12):929-34. PubMed ID: 18347314
    [Abstract] [Full Text] [Related]

  • 20. Relationship between human paraoxonase-1 activity and PON1 polymorphisms in Mexican workers exposed to organophosphate pesticides.
    López-Flores I, Lacasaña M, Blanco-Muñoz J, Aguilar-Garduño C, Sanchez-Villegas P, Pérez-Méndez OA, Gamboa-Avila R.
    Toxicol Lett; 2009 Jul 24; 188(2):84-90. PubMed ID: 19446239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.